Kaposi Sarcoma Market Outlook, Top Key Players, Industry Growth Analysis and Forecast to 2022 Kaposi Sarcoma Market report on is foretold to provide a robust support for industry players to lay a solid foundation for their business growth. It includes a comprehensive evaluation of the market’s growth status and market risk. Furthermore, it provides detail industry analysis - porter’s, market variables, trends & key opportunities. Kaposi Sarcoma is a tumor caused by infection with human herpes virus 8. It is also known as Kaposi sarcoma-associated herpes virus or KS agent. It becomes widely known as one of the AIDS-defining illnesses. It is viral infection. There is a widespread lack of awareness of this even among persons at risk for HHV-8 infection. Kaposi sarcoma (KS) is a systemic disease with cutaneous lesions with or without internal involvement. The Kaposi sarcoma (KS) is considered to be an AIDS-defining disease; indicating that patients with KS go on to develop AIDS. The incidence of Kaposi sarcoma was reportedly high in homosexual men with HIV. Kaposi Sarcoma is different from the other cancers in that lesions may be in more than one place in the body at the same time. These affected areas are called lesions. The skin lesions of KS most often appear on the legs or face and may cause it to swell painfully.